Cefpodoxime Proxetil 200 mg
PROXINA-200 contains cefpodoxime proxetil, an oral third-generation cephalosporin antibiotic. After oral administration, cefpodoxime proxetil is converted to its active form, cefpodoxime.
Cefpodoxime works by inhibiting bacterial cell-wall synthesis. It is used in the treatment of susceptible bacterial infections, according to the approved prescribing information.
Type: Tablets
Packing: 10 x 10 Alu Alu
Oral third-generation cephalosporin antibiotic.
Bactericidal activity through inhibition of bacterial cell-wall synthesis.
Activity against a range of susceptible Gram-positive and Gram-negative bacteria.
Treatment selection should consider the infection, likely pathogen, susceptibility pattern and patient factors.
Indications must follow the approved Indian product label. Potentially relevant therapeutic areas for label verification include:
Selected respiratory tract bacterial infections.
Certain urinary tract bacterial infections.
Selected skin and soft-tissue bacterial infections.
Only retain indications specifically authorised for this formulation. Use under the direction of a registered medical practitioner.
Verified product information, formulation specifications, and commercial supply pathways for registered healthcare professionals, institutions, and trade partners.
Review verified active composition, strength, dosage form, and packaging details on this page.
View SpecificationsRequest formulation literature, technical specifications, or product communication from our commercial team.
Submit Product EnquiryConnect regarding institutional supply requirements, trade distribution, or third-party contract manufacturing.
Commercial EnquiryThis product information is intended for registered healthcare professionals, medical practitioners, and authorized distribution partners. Product manufacturing is coordinated through eligible facility partners under applicable licences.
Request information about PROXINA-200 for professional use.